First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
Alfred B TionoIssa NébiéNicholas AnagnostouAboubacar S CoulibalyGeorgina BowyerErika LamEdith C BougoumaAlphonse OuedraogoJean Baptist B YaroAïssata BarryRachel RobertsTommy RamplingCarly BlissSusanne HodgsonAlison LawrieAmidou OuedraogoEgeruan Babatunde ImoukhuedeKatie J EwerNicola K ViebigAmidou DiarraOdile LeroyPhilip BejonAdrian V S HillSodiomon B SirimaPublished in: PloS one (2018)
ClinicalTrials.gov NCT01635647. Pactr.org PACTR201208000404131.